High Expression of BCL-2 and BCL-Xl in Diffuse Large B-Cell Lymphoma Confer Poor Prognosis but May Be Reversible by Combined Inhibition With Bet Inhibitors and Bh3 Mimetics.
Hematological Oncology - United Kingdom
doi 10.1002/hon.84_2629
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Wiley